Continuous blood glucose monitoring; genetic test for hypothyroidism

It remains unclear whether continuous glucose monitoring benefits people without diabetes, the researchers reported.

In a recent study, they found a discrepancy between the glucose management indicator (GMI), a continuous glucose monitoring measure that estimates HbA1c, and HbA1c measured in the laboratory.

“Based on the results of our study, it would not be appropriate to use GMI as a substitute for HbA1c in people without diabetes,” Viral N. Shah, MD, an associate professor of medicine and pediatrics at the Barbara Davis Center for Diabetes Adult Clinic at the University of Colorado’s Anschutz Medical Campus, Healio told Healio.

It was the first story in endocrinology last week.

The second lead article focused on a study of the potential for using genetic testing to aid in the diagnosis of congenital hypothyroidism in children. The researchers reported that genetic testing led to a change in diagnosis for 10 out of 48 children with congenital hypothyroidism.

Read these and many more endocrinology stories below:

Q&A: CGM metrics may not provide accurate health data for people without diabetes

Continuous glucose monitoring has been firmly established as beneficial for helping people with diabetes understand their glycemic profile, but whether these measurements translate to people without diabetes remains unclear. Learn more.

Genetic testing can help confirm the diagnosis in children with congenital hypothyroidism

Genetic testing can be used to confirm a diagnosis of congenital hypothyroidism in children, according to findings published in the European Thyroid Journal. Learn more.

Standalone player for FreeStyle Libre 3 CGM receives FDA authorisation

The FDA has granted clearance to use a stand-alone meter to display real-time glucose levels with an integrated continuous glucose monitoring system, according to a press release. Learn more.

Low-carb plant-based diet linked to lower mortality risk in type 2 diabetes

Low-carb diets that focus on macronutrients from whole grains, fruits, and vegetables are associated with a lower mortality risk for people with type 2 diabetes, according to study data. Learn more.

Intensive diabetes management does not preserve C-peptide in young people with type 1 diabetes

According to study data, older children with newly diagnosed type 1 diabetes who received intensive diabetes management with automated insulin delivery showed no difference in pancreatic C-peptide levels compared with standard care. Learn more.